Table 4.
Comparison of demographic and clinical characteristics among dead and alive ICU patients infected with multi-resistant P. aeruginosa.
| Characteristic | Outcome | p-Value | |
|---|---|---|---|
| Alive n (%) (Total = 113) |
Dead n (%) (Total = 142) |
||
| Year | |||
| 2019 | 43 (38.1) | 71 (50) | 0.056 |
| 2020 | 43 (38.1) | 35 (24.6) | |
| 2021 | 27 (23.9) | 36 (25.4) | |
| Gender | |||
| Male | 69 (61.1) | 88 (62) | 0.882 |
| Female | 44 (38.9) | 54 (38) | |
| Age | |||
| Adult (19–44 years) | 32 (28.3) | 22 (15.5) | 0.075 |
| Adult (45–64 years) | 29 (25.7) | 43 (30.3) | |
| Adult (65–84 years) | 44 (38.9) | 69 (48.6) | |
| Adult (≥85 years) | 8 (7.1) | 8 (5.6) | |
| Respiratory culture | |||
| Positive | 87 (48.9) | 91 (51.1) | 0.026 * |
| Clinical presentation/infection | |||
| Fever | 21 (18.6) | 13 (9.2) | 0.028 * |
| Sepsis | 9 (8) | 16 (11.3) | 0.378 |
| Septic shock | 8 (7.1) | 32 (22.5) | 0.001 ** |
| Respiratory | 80 (70.8) | 115 (81) | 0.057 |
| GIT | 5 (4.4) | 3 (2.1) | 0.293 |
| UTI | 15 (13.3) | 17 (12) | 0.755 |
| WI | 23 (20.4) | 23 (16.2) | 0.391 |
| Pneumonia | 56 (49.6) | 61 (43) | 0.293 |
| Underlying disease | |||
| Kidney | 32 (28.3) | 58 (40.8) | 0.038 * |
| Heart | 46 (40.7) | 55 (38.7) | 0.749 |
| Liver | 7 (6.2) | 25 (17.6) | 0.006 ** |
| Brain disorder | 41 (36.3) | 27 (19) | 0.002 ** |
| Cancer | 9 (8) | 24 (16.9) | 0.035 * |
| DM | 53 (46.9) | 83 (58.5) | 0.066 |
| Asthma | 6 (5.3) | 2 (1.4) | 0.076 |
| HTN | 70 (61.9) | 82 (57.7) | 0.497 |
| Risk factors | |||
| Mechanical ventilation | 23 (28.3) | 61 (43) | 0.016 * |
| COVID-19 | 15 (3.3) | 22 (15.5) | 0.617 |
Univariate analysis (Fisher’s exact test, p < 0.05). * Statistically significant; the number of * represents the degree of significance. GIT, gastrointestinal tract; UTI, urinary tract infection; WI, wound infection; DM, diabetes mellitus; HTN, hypertension; COVID-19, corona virus disease 2019.